These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. suPAR as a marker of infection in acute kidney injury - a prospective observational study. Hall A; Crichton S; Varrier M; Bear DE; Ostermann M BMC Nephrol; 2018 Aug; 19(1):191. PubMed ID: 30071826 [TBL] [Abstract][Full Text] [Related]
26. [Use of somatosensory evoked potentials for preoperative assessment in patients with severe aneurysmal subarachnoid hemorrhage before surgical or interventional treatment: a prospective observational cohort study]. Zhao J; Luo X; Zhang Z; Chen K; Shi G; Zhou J Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Mar; 30(3):251-256. PubMed ID: 29519285 [TBL] [Abstract][Full Text] [Related]
27. Predictors of excellent functional outcome in aneurysmal subarachnoid hemorrhage. Pegoli M; Mandrekar J; Rabinstein AA; Lanzino G J Neurosurg; 2015 Feb; 122(2):414-8. PubMed ID: 25495745 [TBL] [Abstract][Full Text] [Related]
28. Usefulness of soluble urokinase plasminogen activator receptor to predict repeat myocardial infarction and mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention. Lyngbæk S; Marott JL; Møller DV; Christiansen M; Iversen KK; Clemmensen PM; Eugen-Olsen J; Jeppesen JL; Hansen PR Am J Cardiol; 2012 Dec; 110(12):1756-63. PubMed ID: 22981263 [TBL] [Abstract][Full Text] [Related]
29. Elevated Soluble Urokinase Plasminogen Activator Receptor and Proenkephalin Serum Levels Predict the Development of Acute Kidney Injury after Cardiac Surgery. Mossanen JC; Pracht J; Jansen TU; Buendgens L; Stoppe C; Goetzenich A; Struck J; Autschbach R; Marx G; Tacke F Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758975 [TBL] [Abstract][Full Text] [Related]
30. Neuroglobin as a Novel Biomarker for Predicting Poor Outcomes in Aneurysmal Subarachnoid Hemorrhage. Cai H; Zheng S; Cai B; Yao P; Ding C; Chen F; Kang D World Neurosurg; 2018 Aug; 116():e258-e265. PubMed ID: 29738858 [TBL] [Abstract][Full Text] [Related]
31. Preoperative and postoperative predictors of long-term outcome after endovascular treatment of poor-grade aneurysmal subarachnoid hemorrhage. Zhao B; Yang H; Zheng K; Li Z; Xiong Y; Tan X; Zhong M; J Neurosurg; 2017 Jun; 126(6):1764-1771. PubMed ID: 27367238 [TBL] [Abstract][Full Text] [Related]
32. Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis. Slot O; Brünner N; Locht H; Oxholm P; Stephens RW Ann Rheum Dis; 1999 Aug; 58(8):488-92. PubMed ID: 10419867 [TBL] [Abstract][Full Text] [Related]
34. The diagnostic value of soluble urokinase-type plasminogen activator receptor (suPAR) for the discrimination of vertebral osteomyelitis and degenerative diseases of the spine. Scharrenberg JS; Yagdiran A; Brinkmann J; Brune M; Siewe J; Jung N; Mahabir E J Orthop Surg Res; 2019 Nov; 14(1):367. PubMed ID: 31727136 [TBL] [Abstract][Full Text] [Related]
35. Brain plasticity and neuroinflammatory protein biomarkers with circulating MicroRNAs as predictors of acute brain injury outcome - A prospective cohort study. Sajanti A; Li Y; Hellström S; Cao Y; Girard R; Umemori J; Frantzén J; Koskimäki F; Lyne SB; Falter J; Rantamäki T; Takala R; Posti JP; Roine S; Kolehmainen S; Srinath A; Jänkälä M; Puolitaival J; Rahi M; Rinne J; Castrén E; Koskimäki J J Neurol Sci; 2024 Sep; 464():123169. PubMed ID: 39126731 [TBL] [Abstract][Full Text] [Related]
36. Plasma-soluble urokinase plasminogen activator receptor (suPAR) levels in Behçet's disease and correlation with disease activity. Saylam Kurtipek G; Kesli R; Tuncez Akyurek F; Akyurek F; Ataseven A; Terzi Y Int J Rheum Dis; 2018 Apr; 21(4):866-870. PubMed ID: 27171829 [TBL] [Abstract][Full Text] [Related]
37. Preoperative plasma soluble urokinase plasminogen activator receptor as a prognostic marker in rectal cancer patients. An EORTC-Receptor and Biomarker Group collaboration. Riisbro R; Christensen IJ; Nielsen HJ; Brünner N; Nilbert M; Fernebro E Int J Biol Markers; 2005; 20(2):93-102. PubMed ID: 16011039 [TBL] [Abstract][Full Text] [Related]
38. Risk factors associated with serum levels of the inflammatory biomarker soluble urokinase plasminogen activator receptor in a general population. Haupt TH; Kallemose T; Ladelund S; Rasmussen LJ; Thorball CW; Andersen O; Pisinger C; Eugen-Olsen J Biomark Insights; 2014; 9():91-100. PubMed ID: 25574132 [TBL] [Abstract][Full Text] [Related]